What’s Up to 5x More Expensive than GLP-1s?
Many Asthma medications called “Biologics”. Download our latest paper on the proprietary wearable device & care system for Asthma that is clinically validated as a significant predictor of asthma control (β=–.48, P=.003), quality of life (β=–.55, P=.001), and health care utilization (β=.74, P=.004) after 3 months, and supports all three to reduce costs.
Did you know:
Bigger than GLP-1s
Increasingly popular GLP-1 medications, widely used for diabetes and weight loss, can cost thousands of dollars per month. However, Asthma Biologics, such as Xolair, may cost thousands per dose, with annual expenses exceeding $47,000.
Broad Impact
The annual healthcare costs associated with asthma and COPD in the United States exceed $100 billion. This high expense is largely driven by hospitalizations and emergency department visits due to exacerbations of these conditions.
Real Answers
Download the latest paper on the proprietary wearable device for Asthma that is clinically validated as a significant predictor of asthma control (β=–.48, P=.003), quality of life (β=–.55, P=.001), and health care utilization (β=.74, P=.004) after 3 months, and supports all three to reduce costs.
A Clinically-Validated Wearable & Care System That Changes the Game
Our proprietary wearable device’s data for Asthmatics is clinically validated as a significant predictor of asthma control (β=–.48, P=.003), quality of life (β=–.55, P=.001), and health care utilization (β=.74, P=.004) after 3 months.
Let’s Connect!
Secure an opportunity to discuss Nightingale’s innovative respiratory care solutions directly with CEO Sharon Samjitsingh!